Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism HBV capsid inhibitors(HBV capsid inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H18F4N6O2 |
InChIKeyOZIBIXCYSAMOHV-WDEREUQCSA-N |
CAS Registry2270943-23-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | China | 17 Feb 2022 |